[1]JournalofMedicinalChemistry,2015,vol.58,p.376-400
Title: Pasquier B, et al. Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido,2-apyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumors. J Med Chem. 2015 Jan 8;58(1):376-400.
Title: Jim Baggen, et al. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2. Nat Genet. 2021 Mar 8.